These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 142460)

  • 1. Membranoproliferative glomerulonephritis. One of many diesases?
    Jones DB
    Arch Pathol Lab Med; 1977 Sep; 101(9):457-61. PubMed ID: 142460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M; Sich M; Habib R
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course.
    Venkataseshan VS; Lieberman K; Kim DU; Thung SN; Dikman S; D'Agati V; Susin M; Valderrama E; Gauthier B; Prakash A
    Medicine (Baltimore); 1990 Jul; 69(4):200-16. PubMed ID: 2142748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
    Strife CF; McAdams AJ; West CD
    Clin Nephrol; 1982 Jul; 18(1):9-16. PubMed ID: 6749363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of the complement system in different forms of glomerulonephritis].
    Wegmüller E; Frey B; Hodler J
    Schweiz Med Wochenschr; 1977 Jul; 107(29):1028-34. PubMed ID: 331469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
    Belgiojoso GB; Tarantino A; Bazzi C; Colasanti G; Guerra L; Durante A
    Clin Nephrol; 1976 Jul; 6(1):303-10. PubMed ID: 782750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R; Lévy M; Gubler MC; Broyer M; Habib M
    Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post-infectious glomerulonephritis].
    Barbiano Di Belgiojoso G; Genderini A; Ferrario F
    G Ital Nefrol; 2003; 20(2):184-99. PubMed ID: 12746805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classical complement pathway activation in membranoproliferative glomerulonephritis.
    Ooi YM; Vallota EH; West CD
    Kidney Int; 1976 Jan; 9(1):46-53. PubMed ID: 781380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cryoglobulinemia and mesangio-capillary glomerulonephritis (comparison of the 2 histological types)].
    Losito A; Lorusso L
    Boll Ist Sieroter Milan; 1978 Mar; 57(1):69-75. PubMed ID: 656199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane.
    Strife CF; McEnery PT; McAdams AJ; West CD
    Clin Nephrol; 1977 Feb; 7(2):65-72. PubMed ID: 844227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type III membranoproliferative glomerulonephritis: long-term clinical and morphologic evaluation.
    Strife CF; Jackson EC; McAdams AJ
    Clin Nephrol; 1984 Jun; 21(6):323-34. PubMed ID: 6331934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerulonephritis and Staphylococcal aureus infections.
    Spector DA; Millan J; Zauber N; Burton J
    Clin Nephrol; 1980 Nov; 14(5):256-61. PubMed ID: 7226584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic and secondary mesangiocapillary glomerulonephritis.
    Zamurovic D; Churg J
    Nephron; 1984; 38(3):145-53. PubMed ID: 6387518
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dense intramembranous deposit disease: a clinical comparison of histological subtypes.
    Kashtan CE; Burke B; Burch G; Gustav Fisker S; Kim Y
    Clin Nephrol; 1990 Jan; 33(1):1-6. PubMed ID: 2302866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.